One of the unique opportunities for the industry to come out on scientific and safe manner is to engage closely on the latest developments in the industry, feels Frances Zipp, CEO at Lachman Consultants.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2DkgFdJ
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Indian pharma companies maintaining good compliance standards: Frances Zipp, CEO, Lachman Consultants
0 comments:
Post a Comment